Bivatuzumab mertansine is a combination of bivatuzumab a humanized monoclonal antibody and mertansine a cytotoxic agent. It is designed for the treatment of squamous cell carcinoma.
List of articles in "Drug" category - Page 374
Bertilimumab
Bertilimumab is a human monoclonal antibody that binds to eotaxin-1 an important regulator of overall eosinophil function.It was discovered by Cambridge Antibody Technology using their phage display technology. Named CAT-213 […]
Antrafenine
Antrafenine (Stakane) is a phenylpiperazine derivative drug invented in 1979. It acts as an analgesic and anti-inflammatory drug with similar efficacy to naproxen but is not widely used as it […]
Belimumab
Belimumab (trade name Benlysta previously known as LymphoStat-B) is a human monoclonal antibody that inhibits B-cell activating factor (BAFF) also known as B-lymphocyte stimulator (BLyS). B cells are responsible for […]
Bectumomab
Bectumomab (marketed under the trade name LymphoScan) is a mouse monoclonal antibody labelled with the radioactive isotope technetium-99m. It is used to detect non-Hodgkin’s lymphoma.
Bavituximab
Bavituximab is a chimeric monoclonal antibody designed for the treatment of cancers and viral infections.
Atorolimumab
Atorolimumab is an immunosuppressive drug directed against the Rhesus factor.
Aselizumab
Aselizumab is an immunosuppressive drug which has been investigated for the use in severely injured patients. It binds to CD62L.
Niaprazine
Niaprazine (Nopron) is a sedative-hypnotic drug of the phenylpiperazine class. It has been used in the treatment of sleep disturbances since the early 1970s in several European countries including France […]
Technetium (99mTc) arcitumomab
Technetium (99mTc) arcitumomab is a drug used for the diagnostic imaging of colorectal cancers marketed by Immunomedics. It consists of the Fab’ fragment of a monoclonal antibody (arcitumomab trade name […]